21 May 2009
What else differs cellular rejection grade 1a from 0? annexin v and bcl in elective biopsies received from heart transplant recipients
S Zeglen, J Nozynski, E Wozniak-Grygiel, M Zakliczynski, A Laszewska, M ZembalaAnn Transplant 2009; 14(1): 31-31 :: ID: 880312
Abstract
Background: Despite of morphologic differences between non-rejection (0 due to ISHLT scale) and moderate focal cellular rejection (1a, ISHLT) i.e. lymphocytes aggregation, the genetic and clinical differences in CARGO studies were not shown. Therefore the aim of the study was to compare the expression of selected antigens associated with apoptosis in heart transplant (HTx) recipients in the context of 0 and 1a cellular rejection. The expression of Annexin V, Bcl-2 (protective apoptotic activity), Bcl-xL (antiapoptotic activity) and Bcl-xS/L (other antiapoptotic mechanism) were assessed.
Material/Methods: 17 heart transplant patients were retrospectively included into the trial (2 women and 15 men, mean age 46.2±13.9 yr, BMI 25.7±3.2). 10 biopsies presented rejection 0 and next 10-1a (due to ISHLT scale) - group A and B, respectively. Endomyocardial biopsy specimens were processed using routine immunohistochemical method. The frozen sections were incubated with adequate anti-human antibodies from BioVision and Santa Cruz Biotechnology. The expression was assessed according to IHC method i.e. 0 - the lack of expression, 1 - trace, 2 - distinct and 3 - strong. The correlation was analyzed between particular molecules expression. Results: The significant increase of Bcl-2 expression together with rejection was observed. The expression of other antigens was also shown but without signs of any significant tendency. No correlation in group A was noted, on the contrary, in group B the significant strong and negative correlation between Bcl-2 and Bcl-xS/L was revealed.
Conclusions: Bcl-2 expression responds to the morphologic progression of
graft rejection and is opposing to Bcl-xS/L activity.
Keywords: Heart Transplantation
In Press
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
02 Apr 2024 : Original article
Liver Transplantation from Brain-Dead Donors with Hepatitis B or C in South Korea: A 2014-2020 Korean Organ...Ann Transplant In Press; DOI: 10.12659/AOT.943588
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860